Rotenone produces opposite effects upon mouse striatal dopamine function as a result of environmental temperature

Neurotoxicity Research

Volumn 9, Issue 1, 2006, Pages 15-21

  Crutchfield, Karla C ^a   Dluzen, Dean E ^a  

^a Northeast Ohio Medical University   (United States)

Author keywords

Neurodegeneration; Neurotoxicity; Nigrostriatal; Parkinson's disease

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; INSECTICIDE; METHAMPHETAMINE; ROTENONE;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; BRAIN LEVEL; COMPARATIVE STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG EFFECT; METABOLISM; MOUSE; PHYSIOLOGY; RADIATION EXPOSURE; TEMPERATURE;

3,4-DIHYDROXYPHENYLACETIC ACID; ANALYSIS OF VARIANCE; ANIMALS; BRAIN CHEMISTRY; CORPUS STRIATUM; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; INSECTICIDES; METHAMPHETAMINE; MICE; ROTENONE; TEMPERATURE;

EID: 33645949737     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033303     Document Type: Article

References (34)

1. Alam M and WJ Schmidt (2002) Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats. Behav. Brain Res. 136, 317-324.
2. Antkiewicz-Michaluk L, B Karolewicz, I Romanska, J Michaluk, AJ Bojarski and J Vetulani (2003) 1-methyl-1,2,3,4-tetrahydroisoquinoline protects against rotenone-induced mortality and biochemical changes in rat brain. Eur. J. Pharmacol. 466, 263-269.
3. Bashkatova V, M Alam, A Vanin and WJ Schmidt (2004) Chronic administration of rotenone increases levels of nitric oxide and lipid peroxidation products in rat brain. Exp. Neurol. 186, 235-241.
4. Beal MF (1995) Aging, energy and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38, 357-366.
5. Betarbet R, T Sherer, G MacKenzie, M Carcia-Osuna, A Panov and JT Greenamyre (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3, 1301-1306.
6. Betarbet R, T Sherer and T Greenamyre (2002a) Animal models of Parkinson's disease. BioEssays 24, 308-318.
7. Betarbet R, T Sherer, DA Di Monte and JT Greenamyre (2002b) Mechanistic approaches to Parkinson's disease pathogenesis. Brain Pathol. 12, 499-510. Review.
8. Bowyer JF, AW Tank, GD Newport, W Slikker Jr, SF Ali and R Holson (1992) The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J. Pharmacol. Exp. Ther. 260, 817-824.
9. Brown P, R Wise and E Kiyatkin (2003) Brain hyperthermia is induced by methamphetamine and exacerbated by social interaction. J. Neurosci. 23, 3924-3929.
10. Casarett LJ and J Doull (1973) Factors influencing toxicology, In: Toxicology, The Basic Sciences of Poisons (MacMillan Co.: New York), pp 133-147.
11. Di Monte DA (2003) The environment and Parkinson's disease: Is the nigrostriatal system preferentially targeted by neurotoxins? Lancet Neurol. 2, 531-538.
12. Di Monte DA, M Lavasani and AB Nanning-Bog (2002) Environmental factors in Parkinson's disease. NeuroToxicology 23, 487-502.
13. Dluzen DE, G Story, K Xu, J Kucera and JM Walro (1999) Alterations in nigrostriatal dopaminergic function within BDNF mutant mice. Exp. Neurol. 160, 500-507.
14. Dluzen DE, X Gao, G Story, LI Anderson, J Kucera and JM Walro (2001) Evaluation of nigrostriatal dopaminergic function in adult +/+ and +/- BDNF mutant mice. Exp. Neurol. 170, 121-128.
15. Dluzen DE, LI Anderson, JL McDermott, J Kucera and JM Walro (2002) Striatal dopamine output is compromised within +/- BDNF mice. Synapse 43, 112-117.
16. Dluzen DE, JL McDermott, LI Anderson, J Kucera, JN Joyce, T Osredkar and JM Walro (2004) Age-related changes in nigrostriatal dopaminergic function are accentuated in +/- brain-derived neurotrophic factor mice. Neuroscience 128, 201-208.
17. Fahn S and G Cohen (1992) The oxidative stress hypothesis in Parkinson's disease: Evidence supporting it. Ann. Neurol. 32, 804-812.
18. Ferrante R, J Schulz, N Kowall and F Beal (1997) Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not in the substantia nigra. Brain Res. 753, 157-162.
19. Giasson BI and VM-Y Lee (2000) A new link between pesticides and Parkinson's disease. Nat. Neurosci. 3, 1227-1228.
20. Gordon CJ (2003) Role of environmental stress on the physiological response to chemical toxicants. Environ. Res. 92, 1-7.
21. He Y, SZ Imam, Z Dong, J Jankovic, SF Ali, SH Appel and W Le (2003) Role of nitric oxide in rotenone-induced nigro-striatal injury. J. Neurochem. 86, 1338-1345.
22. Heikkila R, W Nicklas, I Vyas and R Duvoisin (1985) Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridium ion after their stereotaxic administration to rats: Implications for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. Neurosci. Lett. 62, 389-394.
23. 3 receptor concentrations. Synapse 52, 11-19.
24. Lapointe N, M St-Hilaire, M-G Martinoli, J Blanchet, P Gould, C Rouillard and F Cicchetti (2004) Rotenone induces non-specific central nervous system and systemic neurotoxicity. FASEB J. 18, 717-719.
25. Lau Y-S, R Hao, YK Fung, JF Fu, JF Bishop, RF Pfieffer and MM Mouradian (1998) Modulation of nigrostriatal dopaminergic neurotransmission by antisense oligodeoxynucleotide against brain-derived neurotrophic factor. Neurochem. Res. 23, 525-532.
26. Lin PS, S Quamo, KC Ho and J Gladding (1991) Hyperthermia enhances the cytotoxic effects of reactive oxygen species to Chinese hamster cells and bovine endothelial cells in vitro. Radiat. Res. 126, 43-51.
27. Miller D and P O'Callaghan (2003) Elevated environmental temperature and methamphetamine neurotoxicity. Environ. Res. 92, 48-53.
28. Mizuno Y, S. Ohta, M Tanaka, S Takamiya, K Suzuki, T Sato, H Oya, T, Ozawa Y and Y Kagawa (1989) Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem. Biophys. Res. Commun. 163, 1450-1455.
29. + levels and enhances toxicity to dopamine neurons in MPTP-treated mice. Brain Res. 790, 264-269.
30. Omar RA, S Yano and Y Kikkawa (1987) Antioxidant enzymes and survival of normal and simian virus 40-transformed mouse embryo cells after hyperthermia. Cancer Res. 47, 3473-3476.
31. Santiago M, L Granero, A Machado and J Cano (1995) Complex I inhibitor effect on the nigral and striatal release of dopamine in the presence and absence of nomifensine. Eur. J. Pharmacol. 280, 251-256.
32. Schapira AH, JM Cooper, D Dexter, P Jenner, JB Clark and CD Marsden (1989) Mitochondria complex I deficiency in Parkinson's disease. Lancet 1, 1269.
33. Sherer TB, J-H Kim, R Betarbet and JT Greenamyre (2003) Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and α-synuclein aggregation. Exp. Neurol. 179, 9-16.
34. Thiffault C, J Langston and D Di Monte (2000) Increased striatal dopamine turnover following acute administration of rotenone to mice. Brain Res. 885, 283-288.